|
| US-MA, Associate Director/Director Global Outcomes Research- CNS |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Associate Director/Director Global Outcomes Research- CNS |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Associate Director/Director Global Outcomes Research (GI) |
Takeda Pharmaceuticals | 4/22/2018 |
| US-NJ, Assoc. Director Primary Market Research Hospital, Infectious Diseases |
Shionogi | 4/22/2018 |
| US-IL, Lead Market and Customer Insights |
Takeda Pharmaceuticals | 4/22/2018 |
| United States, Director Global HEOR |
ProClinical | 4/22/2018 |
| US-IL, Associate Director, Outcomes Research |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Head of Translational Sciences |
Takeda Pharmaceuticals | 4/22/2018 |
| US-IL, Director - Evidence & Value Generation |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Director Oncology Translational Biomarker Research |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Translational Biomarker Research (Director) - GI / Immunology |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Translational Research Expert, Breakthrough Heme |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Translational Research Lead, Breakthrough Heme |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Translational Research Lead, Redirected Immunity |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Translational Research Expert, Cold to Hot-Tumor Microenvironment |
Takeda Pharmaceuticals | 4/22/2018 |
| US-IL, Lead, Healthcare Insights & Solutions |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Associate Director, Immuno-Oncology Research |
Takeda Pharmaceuticals | 4/22/2018 |
| US-MA, Portfolio Leader in GI Motility/Liver Drug Discovery; Senior Director, GI DDU |
Takeda Pharmaceuticals | 4/22/2018 |
| US-IL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-MA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-FL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-IN, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-PA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-MA, Neuroscience (Neurology / Psychiatry) Therapeutic Area Physician (Cambridge, MA) |
Takeda Pharmaceuticals | 4/22/2018 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-FL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-MA, Senior Clinical Scientist- Oncology |
Takeda Pharmaceuticals | 4/22/2018 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-SC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-CT, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-NY, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-MA, Head of Biologics Research |
Takeda Pharmaceuticals | 4/22/2018 |
| US-CA, Director, Head of Biology, CNS Research - Research and Development San Diego, CA |
Takeda Pharmaceuticals | 4/22/2018 |
| US-PA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-NJ, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-CT, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-NJ, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-IL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-NY, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-SC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
| US-IN, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-MA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/22/2018 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/22/2018 |
Didn't Find What You're Looking For?
|